compound W

03/01/2011 - "Normal progression of maternal serum compound W may be an index of normal fetal thyroid development in mothers with hyperthyroidism treated with necessary antithyroid medication."
03/01/2011 - "Seven mothers with treated hyperthyroidism failed to show an increase in serum levels of compound W after midterm. "
03/01/2011 - "Compound W was measured repeatedly in serum of pregnant women with hyperthyroidism treated with antithyroid medication. "
12/01/1999 - "Moreover, a significant positive correlation was observed between fetal compound W and fetal FT4 values (P<0.005), whereas no correlation was observed between maternal serum compound W and maternal FT4 in either euthyroid or hyperthyroid women, suggesting the fetal origin of compound W. "
10/01/1999 - "A T2S cross-reactive material (compound W) in hyperthyroid patients with trophoblastic disease."

12/01/1999 - "Compound W was also assessed in fetal blood obtained by cordocentesis from 49 normal fetuses and 4 fetuses with suspected hypothyroidism due to transplacental passage of propylthiouracil (PTU). "
12/01/1999 - "The measurement of maternal serum and urinary concentrations of compound W, immunologically similar to but chromatographically distinct from diiodothyronine sulfate (T2S), has been advocated as a new possible marker for fetal hypothyroidism. "
03/01/2007 - "Compound W, a 3,3'-diiodothyronine sulfate (T2S) cross-reactive material in maternal serum, was found to be useful as a marker for fetal hypothyroidism. "
12/01/1999 - "Serial measurements of 3,3'-T2S crossreactive materials (compound W and 3, 3'-diiodothyroacetic acid sulfate) in maternal blood and the administration of TRIAC to the mother may represent a useful and safe alternative to invasive techniques for the diagnosis and therapy of fetal hypothyroidism."

11/01/1986 - "A case of an unusual caustic ingestion involving Compound W, an over the counter wart remover is presented. "

11/01/2012 - "Serum compound W levels were measured by a T(2)S-specific radioimmunoassay in 60 serum samples from newborns with hyperbilirubinemia, age 1-30 d. "